Men with low-to-intermediate grade tumors face a tough choice, with treatment choices that have adverse effects. Although laser ablation has offered an avenue of hope, the U.S. FDA has advised of the potential for tissue overheating in connection with MR-guided, laser interstitial thermal therapy systems.